Single peptide ligand-functionalized uniform hollow mesoporous silica nanoparticles achieving dual-targeting drug delivery to tumor cells and angiogenic blood vessel cells

References

• ArapWPasqualiniRRuoslahtiECancer treatment by targeted drug delivery to tumor vasculature in a mouse modelScience199827953493773809430587
   PubMed Web of Science ®Google Scholar
• QuailDFJoyceJAMicroenvironmental regulation of tumor progression and metastasisNat Med201319111423143724202395
   PubMed Web of Science ®Google Scholar
• YanYBjörnmalmMCarusoFParticle carriers for combating multidrug-resistant cancerACS Nano20137119512951724215340
   PubMedGoogle Scholar
• WuCPHsiehCHWuYSThe emergence of drug transporter-mediated multidrug resistance to cancer chemotherapyMol Pharm2011861996201121770407
   PubMedGoogle Scholar
• EbosJMKerbelRSAntiangiogenic therapy: impact on invasion, disease progression, and metastasisNat Rev Clin Oncol20118421022121364524
   PubMed Web of Science ®Google Scholar
• Pàez-RibesMAllenEHudockJAntiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasisCancer Cell200915322023119249680
   PubMed Web of Science ®Google Scholar
• EbosJMLeeCRCruz-MunozWBjarnasonGAChristensenJGKerbelRSAccelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesisCancer Cell200915323223919249681
   PubMed Web of Science ®Google Scholar
• ValastyanSWeinbergRATumor metastasis: molecular insights and evolving paradigmsCell2011147227529222000009
   PubMed Web of Science ®Google Scholar
• PastorinoFBrignoleCDi PaoloDTargeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacyCancer Res20066620100731008217047071
   PubMed Web of Science ®Google Scholar
• GaoHYangZCaoSTumor cells and neovasculature dual targeting delivery for glioblastoma treatmentBiomaterials20143572374238224342723
   PubMed Web of Science ®Google Scholar
• PanLLiuJHeQShiJMSN – mediated sequential vascular to cell nuclear-targeted drug delivery for efficient tumor regressionAdv Mater201439266742674825159109
   PubMedGoogle Scholar
• GaoHXiongYZhangSYangZCaoSJiangXRGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetrationMol Pharm20141131042105224521297
   PubMed Web of Science ®Google Scholar
• KibriaGHatakeyamaHOhgaNHidaKHarashimaHDual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene deliveryJ Control Release2011153214114821447361
   PubMed Web of Science ®Google Scholar
• SokerSTakashimaSMiaoHQNeufeldGKlagsbrunMNeuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factorCell19989267357459529250
   PubMed Web of Science ®Google Scholar
• BachelderRECragoAChungJVascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cellsCancer Res200161155736574011479209
   PubMed Web of Science ®Google Scholar
• MurgaMFernandez-CapetilloOTosatoGNeuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2Blood200510551992199915522955
   PubMed Web of Science ®Google Scholar
• WangLZengHWangPSokerSMukhopadhyayDNeuropilin-1- mediated vascular permeability factor/vascular endothelial growth factor-dependent endothelial cell migrationJ Biol Chem200327849488484886014514674
   PubMedGoogle Scholar
• PanQChantheryYLiangWCBlocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growthCancer Cell2007111536717222790
   PubMed Web of Science ®Google Scholar
• DallasNAGrayMJXiaLNeuropilin-2-mediated tumor growth and angiogenesis in pancreatic adenocarcinomaClin Cancer Res200814248052806019088020
   PubMed Web of Science ®Google Scholar
• RothLAgemyLKotamrajuVRTranstumoral targeting enabled by a novel neuropilin-binding peptideOncogene201131333754376322179825
   PubMedGoogle Scholar
• AlbericiLRothLSugaharaKNDe novo design of a tumor-penetrating peptideCancer Res201373280481223151901
   PubMed Web of Science ®Google Scholar
• HuQGuGLiuZF3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug deliveryBiomaterials20133441135114523146434
   PubMed Web of Science ®Google Scholar
• HuQGaoXGuGGlioma therapy using tumor homing and penetrating peptide-functionalized PEG–PLA nanoparticles loaded with paclitaxelBiomaterials201334225640565023639530
   PubMedGoogle Scholar
• HeQShiJMesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibilityJ Mater Chem2011211658455855
   Web of Science ®Google Scholar
• HeQShiJMSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibitionAdv Mater201426339141124142549
   PubMed Web of Science ®Google Scholar
• HeQZhangZGaoYShiJLiYIntracellular localization and cytotoxicity of spherical mesoporous silica nano-and microparticlesSmall20095232722272919780070
   PubMedGoogle Scholar
• HeQZhangZGaoFLiYShiJIn vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylationSmall20117227128021213393
   PubMed Web of Science ®Google Scholar
• WuSHMouCYLinHPSynthesis of mesoporous silica nanoparticlesChem Soc Rev20134293862387523403864
   PubMed Web of Science ®Google Scholar
• MamaevaVSahlgrenCLindénMMesoporous silica nanoparticles in medicine – recent advancesAdv Drug Deliv Rev201365568970222921598
   PubMed Web of Science ®Google Scholar
• ShenJSongGAnMThe use of hollow mesoporous silica nanospheres to encapsulate bortezomib and improve efficacy for non-small cell lung cancer therapyBiomaterials201435131632624125776
   PubMed Web of Science ®Google Scholar
• ZhangQZhangTGeJYinYPermeable silica shell through surface-protected etchingNano Lett2008892867287118698725
   PubMed Web of Science ®Google Scholar
• ZhangTGeJHuYZhangQAloniSYinYFormation of hollow silica colloids through a spontaneous dissolution-regrowth processAngew Chem Int Ed Engl20081203158905895
   Google Scholar
• ChenYChenHGuoLHollow/rattle-type mesoporous nanostructures by a structural difference-based selective etching strategyACS Nano20094152953920041633
   PubMedGoogle Scholar
• WuXJXuDSoft template synthesis of yolk/silica shell particlesAdv Mater201022131516152020437501
   PubMedGoogle Scholar
• WangJXiaoQZhouHBudded, mesoporous silica hollow spheres: hierarchical structure controlled by kinetic self-assemblyAdv Mater2006182432843288
   Web of Science ®Google Scholar
• LiuJHartonoSBJinYGA facile vesicle template route to multi-shelled mesoporous silica hollow nanospheresJ Mater Chem2010202245954601
   Google Scholar
• FangXChenCLiuZLiuPZhengNA cationic surfactant assisted selective etching strategy to hollow mesoporous silica spheresNanoscale2011341632163921305093
   PubMedGoogle Scholar
• FangWTangSLiuPFangXGongJZhengNPd nanosheet-covered hollow mesoporous silica nanoparticles as a platform for the chemo-photothermal treatment of cancer cellsSmall20128243816382222903778
   PubMed Web of Science ®Google Scholar
• FangXZhaoXFangWChenCZhengNSelf-templating synthesis of hollow mesoporous silica and their applications in catalysis and drug deliveryNanoscale2013562205221823400270
   PubMedGoogle Scholar
• PanLLiuJHeQWangLShiJOvercoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticlesBiomaterials201334112719273023337327
   PubMed Web of Science ®Google Scholar
• MengHMaiWXZhangHCodelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivoACS Nano201372994100523289892
   PubMed Web of Science ®Google Scholar
• ShenSTangHZhangXTargeting mesoporous silica-encapsulated gold nanorods for chemo-photothermal therapy with near-infrared radiationBiomaterials201334123150315823369218
   PubMed Web of Science ®Google Scholar
• FisichellaMDabboueHBhattacharyyaSMesoporous silica nanoparticles enhance MTT formazan exocytosis in HeLa cells and astrocytesToxicol In Vitro200923469770319254755
   PubMed Web of Science ®Google Scholar
• LaaksonenTSantosHViholaHFailure of MTT as a toxicity testing agent for mesoporous silicon microparticlesChem Res Toxicol200720121913191817990852
   PubMed Web of Science ®Google Scholar
• ArgyoCWeissVBräuchleCBeinTMultifunctional mesoporous silica nanoparticles as a universal platform for drug deliveryChem Mater2013261435451
   Web of Science ®Google Scholar
• QuailDFJoyceJAMicroenvironmental regulation of tumor progression and metastasisNat Med201319111423143724202395
   PubMed Web of Science ®Google Scholar
• KangTGaoXHuQiNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomasBiomaterials201435144319433224565520
   PubMed Web of Science ®Google Scholar
• ZhuSQianLHongMZhangLPeiYJiangYRGD-Modified PEG-PAMAM-DOX conjugate: in vitro and in vivo targeting to both tumor neovascular endothelial cells and tumor cellsAdv Mater20112312H84H8921360776
   PubMed Web of Science ®Google Scholar
• KaksonenMToretCPDrubinDGHarnessing actin dynamics for clathrin-mediated endocytosisNat Rev Mol Cell Biol20067640441416723976
   PubMed Web of Science ®Google Scholar